A pilot study of interferon alpha suppository treatment for chronic hepatitis C
Phase 1
- Conditions
- Chronic hepatitis C
- Registration Number
- JPRN-UMIN000001744
- Lead Sponsor
- Osaka Prefectural General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Previous or present treatment with interferon, average daily intake of alcohol exceeding 50g of ethanol, choledocholithiasis, cirrhosis, autoimmune hepatitis, primary biliary cirrhosis, hepatitis B virus infection, human immunodeficiency virus infection, drug abuser, drug-related liver disease and pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antiviral effect (decline of the viral load)
- Secondary Outcome Measures
Name Time Method (1)Improvement of liver function (2)Adverse effect